We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesNeuroone Medical Technologies Corp

Neuroone Medical Technologies Corp

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.8399 USD 0.04 ( 4.67%)
Last update at 2026-11-12T15:38:00Z
VOLUME
23099
Market Cap
27.10M

Momentum Score

…

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.77
Low
0.84
High
52 Week Price Range
0.85
Low
2.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.80
Dividend Yield
-
Revenue TTM
2.82M
Revenue Per Share
0.14
Gross Profit TTM
-3.05M
Debt / Equity
0.02
ROE
-214.01%
Net Debt
-7.96M
ROCE
-189.62%
Diluted EPS TTM
-0.54

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Income before tax -11.86M -10.00M -9.95M -13.64M -6.78M
Net income -11.86M -10.00M -9.95M -13.64M -6.78M
Selling general administrative 6.75M 6.71M 6.26M 4.75M 4.28M
Selling and marketing expenses 0.17M 0.27M 0.34M - -
Gross profit 0.46M -0.07M -0.10M 0.06M -0.03M
Reconciled depreciation 0.20M 0.12M 0.08M 0.05M 0.03M
Ebit -11.96M -10.03M -9.95M -4.90M -5.81M
Ebitda -11.76M -9.91M -9.87M -4.85M -5.79M
Depreciation and amortization 0.20M 0.12M 0.08M 0.05M 0.03M
Operating income -11.96M -10.03M -10.22M -4.90M -5.81M
Other operating expenses 13.91M 10.20M 10.40M 4.90M 5.81M
Interest expense - 0.03M 0.00M 7.52M 0.28M
Tax provision 0.00M 0.00M - - -
Net interest income - 0.00M -0.00M -7.52M -0.28M
Income tax expense -0.20M -0.03M 0.27M 7.52M 0.28M
Total revenue 1.95M 0.17M 0.18M 1.93M 0.00M
Total operating expenses 12.41M 9.96M 10.12M 4.90M 5.81M
Cost of revenue 1.50M 0.24M 0.28M 1.86M 0.03M
Total other income expense net 0.10M 0.03M 0.27M -1.21M -0.68M
Net income from continuing ops -11.86M -10.00M -9.95M -13.64M -6.78M
Net income applicable to common shares - -10.00M -9.95M -13.64M -6.78M
Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Total assets 8.10M 12.82M 7.94M 4.76M 0.53M
Intangible assets - 0.11M 0.13M 0.16M 0.18M
Other current assets - 0.30M 0.24M 0.12M 0.04M
Total liab 1.85M 3.22M 1.38M 2.69M 1.77M
Total stockholder equity 6.25M 9.60M 6.55M 2.07M -1.24M
Other current liab - 0.63M 0.53M 0.45M 0.62M
Common stock - 0.02M 0.04M 0.02M 0.01M
Capital stock 0.02M 0.02M 0.04M 0.02M 0.01M
Retained earnings -62.69M -50.83M -40.83M -30.88M -17.24M
Other assets - - 7.79M - -
Cash 5.32M 8.16M 6.90M 4.04M 0.26M
Total current liabilities 1.79M 3.10M 1.18M 2.36M 1.77M
Current deferred revenue - 1.46M 0.01M 0.07M -
Net debt - -7.96M -6.59M -2.72M -0.26M
Short term debt - 0.08M 0.11M 1.07M -
Short long term debt - - - 1.01M -
Short long term debt total - 0.20M 0.32M 1.32M -
Other stockholder equity - 60.41M 47.35M 32.92M 15.99M
Property plant equipment - 0.53M 0.51M 0.45M 0.05M
Total current assets 7.31M 12.18M 7.29M 4.16M 0.30M
Net tangible assets - 9.49M 6.42M 1.91M -1.42M
Short term investments 0.00M 2.98M - - -
Net receivables 0.00M 0.03M 0.05M - -
Inventory 1.73M 0.70M 0.10M - -
Accounts payable 0.69M 0.93M 0.53M 0.76M 1.15M
Accumulated other comprehensive income - - - - -0.01M
Common stock total equity - - - 0.02M 0.01M
Non currrent assets other - - - 0.16M 0.23M
Non current assets total 0.78M 0.65M 0.65M 0.60M 0.23M
Capital lease obligations 0.06M 0.20M 0.32M 0.31M -
Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Investments 2.65M -3.24M -0.07M -0.12M -0.12M
Change to liabilities - 0.52M -0.35M -0.27M 0.77M
Total cashflows from investing activities - -3.24M -0.07M -0.12M -0.12M
Net borrowings - - - 8.36M -0.28M
Total cash from financing activities 7.40M 12.02M 11.53M 7.32M 5.77M
Change to operating activities - 1.29M -0.02M -0.16M -0.87M
Net income -11.86M -10.00M -9.95M -13.64M -6.78M
Change in cash -2.84M 1.26M 2.86M 3.78M 0.25M
Begin period cash flow 8.16M 6.90M 4.04M 0.26M 0.01M
End period cash flow 5.32M 8.16M 6.90M 4.04M 0.26M
Total cash from operating activities -12.89M -7.52M -8.60M -3.43M -5.40M
Issuance of capital stock 8.59M 13.35M 8.83M 0.39M 4.56M
Depreciation 0.20M 0.12M 0.08M 0.05M 0.03M
Change to inventory -1.02M -0.61M -0.10M -0.10M -0.10M
Change to account receivables 0.03M 0.02M -0.05M -0.05M -0.05M
Sale purchase of stock -0.12M - - - -
Other cashflows from financing activities - -1.33M 2.71M 6.93M 1.73M
Change to netincome - 1.15M 1.77M 8.69M 1.23M
Capital expenditures 0.38M 0.28M 0.07M 0.12M 0.12M
Change in working capital -2.43M 1.21M -0.51M -0.43M -0.10M
Stock based compensation 1.11M 0.95M 1.79M 1.84M 0.49M
Other non cash items 0.11M 0.20M -0.02M 6.74M 0.28M
Free cash flow -13.27M -7.79M -8.67M -3.55M -5.52M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NMTC
Neuroone Medical Technologies Corp		 0.04
4.67%		 0.84 - - 10.87 6.93 9.97 -2.10
ABT
Abbott Laboratories		 -0.71
0.65%		 108.58 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 0.28
0.28%		 101.89 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -2.16
0.68%		 316.63 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -
-%		 47.31 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Neuroone Medical Technologies Corp

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

7599 Anagram Drive, Eden Prairie, MN, United States, 55344

952 426 1383

https://www.n1mtc.com

16

Name Title Year Born
Mr. David A. Rosa M.D. Pres, CEO & Director 1964
Mr. Ronald W. McClurg Chief Financial Officer 1959
Mr. Steven Mertens Chief Technology Officer 1963
Mr. Mark Christianson Co-Founder, Bus. Devel. Director & Medical Sales Liaison 1967
Mr. Hijaz Haris VP of Marketing NA
Mr. David A. Rosa M.D. President, CEO & Director 1964
Mr. Ronald W. McClurg Chief Financial Officer 1960
Mr. Mark Christianson Co-Founder, Business Development Director & Medical Sales Liaison 1967
Mr. Christopher R. Volker CFA Chief Operating Officer NA
Mr. Hijaz Haris Vice President of Marketing NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…